Old Web
English
Sign In
Acemap
>
Paper
>
Outcome with Hypomethylating Agent and Venetoclax Combination in Patients with Chronic Myelomonocytic Leukemia
Outcome with Hypomethylating Agent and Venetoclax Combination in Patients with Chronic Myelomonocytic Leukemia
2021
Somedeb Ball
Akriti G Jain
Luis E. Aguirre
Najla Al Ali
Yumeng Zhang
Onyee Chan
Andrew T. Kuykendall
Kendra Sweet
Jeffrey E. Lancet
Eric Padron
David M. Swoboda
Rami S. Komrokji
David A. Sallman
Keywords:
Hypomethylating agent
Oncology
Venetoclax
Internal medicine
Outcome (game theory)
Chronic myelomonocytic leukemia
in patient
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]